Managers / Q1 2019 · view latest →
ALTERNA WEALTH MANAGEMENT, INC
CIK 0001767699 · 2800 POST OAK BLVD, SUITE 6300, HOUSTON, TX, 77056 · 713-885-9843
Summary
Alterna Wealth Management, Inc reported $118M in U.S.-listed holdings across 109 positions for Q1 2019.
Its largest position, Ishares Tr, represents 5.6% of the portfolio.
Compared with Q4 2018, the fund opened 67 new positions and exited 268.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 45.7% · $98M
- ETP · 38.0% · $81M
- Other · 11.1% · $24M
- ADR · 4.6% · $10M
- REIT · 0.3% · $563,000
- Other · 0.3% · $675,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2018 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ISHARES TR | NEW | +116.5K | 116.5K | +$7M | $7M |
| ISHARES TR | NEW | +120.2K | 120.2K | +$4M | $4M |
| ISHARES TR | NEW | +43.9K | 43.9K | +$4M | $4M |
| LRCXEURLAM RESEARCH CORP | NEW | +14.5K | 14.5K | +$3M | $3M |
| SELECT SECTOR SPDR TR | NEW | +34.2K | 34.2K | +$3M | $3M |
| L3 TECHNOLOGIES INC | NEW | +11.1K | 11.1K | +$2M | $2M |
| FCXFREEPORT-MCMORAN INC | NEW | +173.0K | 173.0K | +$2M | $2M |
| TARO PHARMACEUTICAL INDS LTD | NEW | +20.5K | 20.5K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ISHARES TRREVEALED | MIN VOL USA ETF · MULTIFACTOR USA · 1 3 YR TREAS BD · FLTG RATE NT ETF · SHORT TREAS BD · US HLTHCARE ETF · IBONDS DEC21 ETF · IBONDS DEC20 ETF · IBONDS DEC19 ETF · MSCI UK ETF NEW | 28.44% | $34M | 777.2K |
| 2 | TAT&T INCREVEALEDhistory → | COM | 8.69% | $10M | 344.6K |
| 3 | AAPLAPPLE INCREVEALEDhistory → | COM | 8.20% | $10M | 55.5K |
| 4 | METAFACEBOOK INCREVEALEDhistory → | CL A | 6.01% | $7M | 48.4K |
| 5 | GILDGILEAD SCIENCES INCREVEALEDhistory → | COM | 5.25% | $6M | 97.3K |
| 6 | ISHARES INCREVEALED | MSCI TURKEY ETF · MIN VOL EMRG MKT | 4.97% | $6M | 193.5K |
| 7 | LRCXEURLAM RESEARCH CORPREVEALEDhistory → | COM | 4.73% | $6M | 36.5K |
| 8 | CVSCVS HEALTH CORPREVEALEDhistory → | COM | 4.56% | $5M | 90.7K |
| 9 | CELGCELGENE CORPREVEALEDhistory → | COM | 4.51% | $5M | 69.8K |
| 10 | L3 TECHNOLOGIES INCREVEALED | COM | 4.29% | $5M | 27.1K |
| 11 | GSGOLDMAN SACHS GROUP INCREVEALEDhistory → | COM | 4.18% | $5M | 27.6K |
| 12 | FCXFREEPORT-MCMORAN INCREVEALEDhistory → | CL B | 4.08% | $5M | 424.0K |
| 13 | TARO PHARMACEUTICAL INDS LTDREVEALED | SHS | 3.92% | $5M | 49.0K |
| 14 | AMZNAMAZON COM INCREVEALEDhistory → | COM | 3.65% | $4M | 2.6K |
| 15 | R6C2ROYAL DUTCH SHELL PLCREVEALEDhistory → | SPON ADR B | 2.99% | $4M | 56.8K |
| 16 | GOOGLALPHABET INC | CAP STK CL A · CAP STK CL C | 2.58% | $3M | 2.6K |
| 17 | GMGENERAL MTRS COREVEALEDhistory → | COM | 2.24% | $3M | 79.0K |
| 18 | UTXZUNITED TECHNOLOGIES CORPhistory → | COM | 2.19% | $3M | 20.1K |
| 19 | SELECT SECTOR SPDR TR | TECHNOLOGY | 2.14% | $3M | 34.2K |
| 20 | TEVATEVA PHARMACEUTICAL INDS LTDREVEALEDhistory → | SPONSORED ADR | 1.81% | $2M | 138.6K |
| 21 | VVISA INChistory → | COM CL A | 1.59% | $2M | 12.1K |
| 22 | ALXNALEXION PHARMACEUTICALS INChistory → | COM | 1.30% | $2M | 11.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | $174M | 109 | Jul 16, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q1 2026 | $132M | 105 | Apr 27, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $120M | 101 | Jan 23, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $121M | 97 | Oct 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $125M | 105 | Aug 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $132M | 109 | Apr 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $119M | 103 | Jan 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $111M | 101 | Oct 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $114M | 108 | Jul 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $123M | 98 | May 3, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $83M | 77 | Feb 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $78M | 71 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $86M | 108 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $80M | 108 | May 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $89M | 98 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $84M | 87 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $98M | 88 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $119M | 119 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $120M | 129 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $79M | 88 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $69M | 87 | Oct 19, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $84M | 95 | Jul 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $69M | 75 | May 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $90M | 113 | Jan 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $85M | 127 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $83M | 105 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $118M | 109 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $518M | 299 | Feb 26, 2019 | RESTATEMENT | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.